BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Martinez MA, Franco S. Impact of COVID-19 in Liver Disease Progression. Hepatol Commun 2021. [PMID: 34222744 DOI: 10.1002/hep4.1745] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Saha P, Bose S, Srivastava AK, Chaudhary AA, Lall R, Prasad S. Jeopardy of COVID-19: Rechecking the Perks of Phytotherapeutic Interventions. Molecules 2021;26:6783. [PMID: 34833873 DOI: 10.3390/molecules26226783] [Reference Citation Analysis]
2 Bizkarguenaga M, Bruzzone C, Gil-Redondo R, SanJuan I, Martin-Ruiz I, Barriales D, Palacios A, Pasco ST, González-Valle B, Laín A, Herrera L, Azkarate A, Vesga MA, Eguizabal C, Anguita J, Embade N, Mato JM, Millet O. Uneven metabolic and lipidomic profiles in recovered COVID-19 patients as investigated by plasma NMR metabolomics. NMR Biomed 2021;:e4637. [PMID: 34708437 DOI: 10.1002/nbm.4637] [Reference Citation Analysis]
3 Zarei M, Bose D, Nouri-Vaskeh M, Tajiknia V, Zand R, Ghasemi M. Long-term side effects and lingering symptoms post COVID-19 recovery. Rev Med Virol 2021;:e2289. [PMID: 34499784 DOI: 10.1002/rmv.2289] [Reference Citation Analysis]
4 Nuovo GJ, Suster D, Awad H, Michaille JJ, Tili E. The histologic and molecular correlates of liver disease in fatal COVID-19 including with alcohol use disorder. Ann Diagn Pathol 2021;57:151881. [PMID: 34968863 DOI: 10.1016/j.anndiagpath.2021.151881] [Reference Citation Analysis]